T2 Biosystems Net Income vs. Cash Per Share

TTOODelisted Stock  USD 0.18  0.05  21.74%   
Based on T2 Biosystems' profitability indicators, T2 Biosystems may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in April. Profitability indicators assess T2 Biosystems' ability to earn profits and add value for shareholders.
For T2 Biosystems profitability analysis, we use financial ratios and fundamental drivers that measure the ability of T2 Biosystems to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well T2 Biosystems utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between T2 Biosystems's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of T2 Biosystems over time as well as its relative position and ranking within its peers.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
Please note, there is a significant difference between T2 Biosystems' value and its price as these two are different measures arrived at by different means. Investors typically determine if T2 Biosystems is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, T2 Biosystems' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

T2 Biosystems Cash Per Share vs. Net Income Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining T2 Biosystems's current stock value. Our valuation model uses many indicators to compare T2 Biosystems value to that of its competitors to determine the firm's financial worth.
T2 Biosystems is rated below average in net income category among its peers. It is rated below average in cash per share category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value T2 Biosystems by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for T2 Biosystems' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

TTOO Cash Per Share vs. Net Income

Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

T2 Biosystems

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
(50.08 M)
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

T2 Biosystems

Cash Per Share

 = 

Total Cash

Average Shares

 = 
1.87 X
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.

TTOO Cash Per Share Comparison

T2 Biosystems is currently under evaluation in cash per share category among its peers.

T2 Biosystems Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in T2 Biosystems, profitability is also one of the essential criteria for including it into their portfolios because, without profit, T2 Biosystems will eventually generate negative long term returns. The profitability progress is the general direction of T2 Biosystems' change in net profit over the period of time. It can combine multiple indicators of T2 Biosystems, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts. T2 Biosystems operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 182 people.

TTOO Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on T2 Biosystems. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of T2 Biosystems position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the T2 Biosystems' important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in T2 Biosystems without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run FinTech Suite Now

   

FinTech Suite

Use AI to screen and filter profitable investment opportunities
All  Next Launch Module

Use Investing Themes to Complement your T2 Biosystems position

In addition to having T2 Biosystems in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Sports Thematic Idea Now

Sports
Sports Theme
Companies in sporting activities arena as well as manufacturers of sporting goods and sport retailers. The Sports theme has 25 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sports Theme or any other thematic opportunities.
View All  Next Launch
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Consideration for investing in TTOO Pink Sheet

If you are still planning to invest in T2 Biosystems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the T2 Biosystems' history and understand the potential risks before investing.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets